Mechanistic comparison of Chlormadinone Acetate and Medroxyprogesterone Acetate based on molecular target overlap from BindingDB and ChEMBL binding affinity data.
19
Shared Targets
42%
Jaccard Similarity
36%
IDF-Weighted Similarity
Jaccard measures raw target overlap. IDF-weighted downweights promiscuous hub targets (e.g. CYP enzymes) that bind many compounds non-specifically.
Chlormadinone and Medroxyprogesterone share 19 molecular targets based on binding affinity data from BindingDB (Kd/IC50 ≤ 10 µM) and ChEMBL. A Jaccard index of 0.422 means 42% of the combined target set is bound by both compounds. The IDF-weighted score of 0.355 accounts for non-specific binding to metabolic enzymes.
Note: High target overlap does not imply identical mechanism or therapeutic equivalence. Binding affinity, tissue distribution, bioavailability, and downstream signaling differ significantly between compounds even when they bind the same protein.
Frequently Asked Questions
What do Chlormadinone and Medroxyprogesterone have in common?
Chlormadinone and Medroxyprogesterone share 19 molecular targets with a Jaccard similarity of 42%. Both bind overlapping sets of proteins based on BindingDB and ChEMBL binding affinity data.
Can Chlormadinone and Medroxyprogesterone be combined?
Chlormadinone and Medroxyprogesterone share 19 molecular targets, suggesting potential pathway overlap. Combination use should be evaluated with a qualified healthcare professional. BiohacksAI does not provide medical advice.
Which has more research: Chlormadinone or Medroxyprogesterone?
In the BiohacksAI corpus: Chlormadinone has 300 PubMed-indexed studies, Medroxyprogesterone has 299 studies.